POSITRON CORPORATION Inactive Instrument
Positron Corporation Stock Other OTC
Equities
POSC
US7373976049
Advanced Medical Equipment & Technology
Financials (USD)
| Sales 2013 | 1.63M | Sales 2014 | 1.47M | Capitalization | 7.26M |
|---|---|---|---|---|---|
| Net income 2013 | -7M | Net income 2014 | -2M | EV / Sales 2013 | 6.92 x |
| Net Debt 2013 | 4.31M | Net Debt 2014 | 862K | EV / Sales 2014 | 5.54 x |
| P/E ratio 2013 |
-0.98
x | P/E ratio 2014 |
-1.86
x | Employees | - |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 95.99% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Adel Abdullah
PSD | President | 51 | - |
Karen Barry
ADM | Chief Administrative Officer | - | - |
| Sales & Marketing | - | 22-06-23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Adel Abdullah
PSD | President | 51 | - |
Tis Prager
BRD | Director/Board Member | - | - |
Positron Corporation is a molecular imaging device company, which offers a positron emission tomography (PET) imaging system and clinical services to nuclear medicine healthcare providers throughout North America. The Company is specialized in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. Its PET technology, clinical services and imaging practice solutions enables healthcare providers to diagnose coronary artery disease and improve patient outcomes through providing medicine. It offers nuclear cardiologists its Attrius PET nuclear imaging device, technical and clinical services, and can provide financing solutions to meet the needs of hospitals and medical imaging practices. Its products and services enables healthcare providers to diagnose CAD and improve patient outcomes.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.02% | 14.49B | |
| -39.19% | 2.78B | |
| -13.76% | 2.42B | |
| -11.53% | 1.47B | |
| -.--% | 1.12B | |
| +40.03% | 515M | |
| +8.39% | 233M | |
| +1.11% | 183M | |
| -.--% | 168M |
